Home › Funds › First Turn Management, LLC › CYTK

First Turn Management, LLC position in CYTK

CYTOKINETICS INC COM NEW · Health Care

First Turn Management, LLC reported holding 527,412 shares of CYTK (CYTOKINETICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$44.9M, representing 4.81% of its reported portfolio and ranking #8 among its reported holdings. First Turn Management, LLC has disclosed CYTK holdings in 8 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)527.41K sh
Reported value held$44.93M
Portfolio Weight4.81%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How First Turn Management, LLC's CYTK position evolved

First Turn Management, LLC first disclosed a stake in CYTK in Q4 2023 at 807,444 shares (US$67.4M). Across 8 filings, First Turn Management, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 527,412 shares valued at US$44.9M — an increase of 243,712 shares quarter over quarter.. Notable position changes include a 47% trim in Q1 2024 (shares fell 23% over the following quarter), a 32% trim in Q2 2024 (shares fell 3% over the following quarter), a 86% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 807.44K $67.41M New
Q1 2024 430.35K $30.17M Reduce
Q2 2024 293.32K $15.89M Reduce
Q3 2024 223.15K $11.78M Reduce
Q3 2025 254.79K $14.00M New
Q4 2025 325.67K $20.69M Add
Q1 2026 283.70K $18.70M Reduce
Q2 2026 527.41K $44.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC COM NEW) is a Health Care company. 51 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has First Turn Management, LLC held CYTK?

First Turn Management, LLC has disclosed CYTK holdings in 8 of the last 11 reported quarters, going back to Q4 2023.

What is First Turn Management, LLC's current position in CYTK?

As of Q2 2026, First Turn Management, LLC holds 527.41K shares of CYTK (CYTOKINETICS INC COM NEW), valued at $44.93M, representing 4.81% of its reported portfolio and ranking #8.

Has First Turn Management, LLC been buying or selling CYTK?

In the latest 13F filing (Q2 2026), First Turn Management, LLC increased its position in CYTK.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.